The Columbia-Suicide Severity Rating Scale (C–SSRS): Has the “Gold Standard” Become a Liability?

Innovations in Clinical Neuroscience

Kathy Harnett Sheehan¹  Jennifer M. Giddens¹  David V. Sheehan¹ 

[1] J. Giddens is the Co-founder of the Tampa Center for Research on Suicidality, Tampa, Florida; Dr. K. Sheehan is Associate Professor Emeritus at the University of South Florida College of Medicine, Tampa, Florida; and Dr. D. Sheehan is Distinguished University Health Professor Emeritus at the University of South Florida College of Medicine, Tampa, Florida.

关键词: Suicide scale;    suicide assessment;    suicide risk;    suicide attempt;    suicide;    suicidal ideation;    suicidal behavior;    suicidality;    C-SSRS;    FDA 2012 Draft Guidance Document;   

DOI  :  

学科分类：精神健康和精神病学

来源: Matrix Medical Communications, LLC

【 摘 要 】

Objective: The Columbia– Suicide Severity Rating Scale has become the gold standard for the assessment of suicidal ideation and behavior in clinical trials. Criticism of the instrument has been mounting. We examine whether the instrument meets widely accepted psychometric standards and maps to the United States Food and Drug Administration’s most recent 2012 algorithm for assessment of suicidal phenomena. Our goal is to determine if the Columbia–Suicide Severity Rating Scale should be retained as the preferred instrument for assessment of suicidal ideation and behavior.

【 授权许可】

Unknown